 Vident Investment Advisory LLC cut its stake in shares of Cellular Biomedicine Group Inc NASDAQ:CBMG by 24.0 in the 1st quarter, according to the company in its most recent filing with the Securities Exchange Commission. The fund owned 13,282 shares of the biotechnology companys stock after selling 4,197 shares during the period. Vident Investment ... 